期刊
JOURNAL OF ECT
卷 27, 期 4, 页码 E61-E62出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/YCT.0b013e31821a8f05
关键词
schizophrenia; treatment resistant; clozapine; ECT; cognition
For treatment-refractory schizophrenia, electroconvulsive therapy (ECT) remains controversial because of its cognitive adverse effects. We report here on clinical and cognitive outcomes of a treatment-resistant schizophrenia patient treated with clozapine and right unilateral ECT. The patient was administered 300 mg of clozapine and 12 right unilateral ECT sessions. Psychopathology was rated by means of the Positive and Negative Syndrome Scale. The neurocognitive test battery included the Wisconsin Card Sorting Test, the Munchner Gedachtnis Test, an attentional performance test, the Trail Making Test, and the Hamburger-Wechsler Intelligence Test. The Positive and Negative Syndrome Scale total score decreased, and all cognitive measures improved. Electroconvulsive therapy would seem to be a safe treatment option for treatment-refractory schizophrenia patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据